IFNG and melanoma: Studies based on both melanoma cell lines and a mouse model have shown that treatment of BRAF-mutated melanoma cells with monotherapy directed against BRAF increased T cell infiltration into tumors and upregulated the expression of MDA and MHC class I/II (in the last case, by increasing IFN-γ levels) [39,40].